Central Pa Transplant Foundatn Inc

Nonprofit profile at a glance

EIN
251857128
IRS 990 coverage
2010–2024
Forms available
Form 990 2024
Location
Harrisburg, PA, USA
Phone
7172318804
Rating
67
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Medical Disciplines Research

Reported finances

Revenue
$95,592
Expenses
$94,443
Assets
$55,219
Liabilities
$13,116

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

3 people listed

Executive titles in this filing

  • HAROLD C YANG MD (PRESIDENT)

People named in this filing

  • JONATHAN R DIAMOND (DIRECTOR)
  • HAROLD C YANG MD (PRESIDENT)
  • MARY M WAYBILL (PHYSICIAN)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

To promote and foster advances in transplantation thru activities that have included participation in clinical trials investigating different immunosuppressive regimens, development of clinical pathways to enhance patient care, forums for public and physician education in transplanta- tion, studies related to outcomes research, laboratory work in immunobiology and new concepts in diabetes management.

What it reported doing in 2024

1. Vitaeris protocol vktx01 "a pivotal phase 3 trial to evaluate the safety and efficacy of clazakizumab for the treatment of chronic active-medicated rejection in kidney transplant recipients". April 2019-december 2024. 2. Apol 1 long-term kidney transplantation outcomes network protocol summary for non-engaged sites (apollo) nih sponsored. March 2020-present. 3. Natera protocol 20-048-trp "renasight clinical application, review, and evaluation (renacare) study december 2021-july 2024. 4. Eledon bestow protocol at-1501-k207 "a phase 2, multicenter, randomized, open-label study to evaluate the safety and efficacy of tegoprubart in patients undergoing kidney transplantation" august 2023-present (active).

Operating model

Revenue model
Earned-program. 99% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. A relatively small share of total spending goes to programs and some filing-based governance responses are negative or unanswered.

Rating breakdown

  • Financial Efficiency: 75
  • Transparency & Controls: 83
  • Accountability: 51
  • Sustainability: 41
  • Growth: 0

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 100%; rating input score 100
  • Program expense ratio: 57.8%; rating input score 58
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 91.7%; rating input score 92; 22nd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 66.7%; rating input score 67; 22nd percentile among comparable filings
  • Governance controls: 2 of 7 controls in place; rating input score 29
    • Conflict-of-interest policy: Fail
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 1.2%; rating input score 57; 57th percentile among comparable filings
  • Total-asset coverage ratio: 0.58; rating input score 18; 18th percentile among comparable filings
  • Liabilities to assets ratio: 0.24; rating input score 14; 14th percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 60; 60th percentile among comparable filings

Growth

  • Program expense growth: -10.8% per year; rating input score 0; 28th percentile among comparable filings
  • Revenue growth: -5.7% per year; rating input score 0; 41st percentile among comparable filings
  • Asset growth: -14.9% per year; rating input score 0; 10th percentile among comparable filings

Details

  • Where the money goes: 100% of revenue deployed · 57.8% of spending went to programs
  • Governance: 2 of 3 board members independent · 2 of 7 filing controls reported
  • Programs: 2 filed program accomplishments · $55K in reported program spending
  • Leadership: top reported pay $0 · 3 people listed
  • Consistency: 16 of 17 current checks pass · 1 finding to review
  • Schedules: 3 filed schedules
  • Filing history: 15 filing years from 2010 to 2024
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Review — Financial Efficiency: Program expense ratio scored 58/100.
  • High — Accountability: Governance controls: 4 of 6 not reported.
  • High — Growth: Program expense growth scored 0/100.
  • High — Growth: Revenue growth scored 0/100.
  • Moderate — Transparency & Controls: Schedule A contributions reconciliation did not reconcile in the filed values.
  • High — Sustainability: Total-asset coverage ratio scored 18/100.
  • Review — Sustainability: Operating margin scored 57/100.
  • High — Growth: Asset growth scored 0/100.
  • High — Sustainability: Liabilities to assets ratio scored 14/100.